학술논문
TOP-077 - Safety, tolerability, and preliminary efficacy of ascending doses of Human Allogeneic Liver-derived Progenitor Cells (HepaStem®) in patients with cirrhotic and pre-cirrhotic non-alcoholic steatohepatitis (NASH)
Document Type
Abstract
Author
Source
In Journal of Hepatology June 2023 78 Supplement 1:S807-S808
Subject
Language
ISSN
0168-8278